FDA approves Ebglyss for moderate-to-severe atopic dermatitis
The U.S. Food and Drug Administration has approved Eli Lilly's Ebglyss (lebrikizumab-lbkz) for adults and children aged 12 ...
FiercePharma3d
Intercept's liver med Ocaliva takes heat at FDA expert meeting, as hopes for full approval dim
Following a meeting with the FDA’s Gastrointestinal Drug Advisory Committee Friday, the future of Intercept’s rare liver ...
thecardiologyadvisor.com6d
FDA Approves Expanded CHF Indication for Furoscix
The FDA has expanded the approval of Furoscix to include treatment of congestion due to fluid overload in adult patients with ...
WIBC2d
FDA Approves Eli Lilly Treatment for Eczema
INDIANAPOLIS–The U.S. Food and Drug Administration has approved Eli Lilly’s new treatment for moderate to severe eczema. It’s ...
Entact Bio Appoints Ruben Tommasi, Ph.D., as Chief Scientific Officer
Entact Bio, a company committed to improving the lives of patients by developing precision medicines that enhance the ...
FierceBiotech1d
FDA scraps adcomm for Applied's rare disease drug ahead of November decision
After pushing back the decision date for Applied Therapeutics’ metabolic disorder drug govorestat, the FDA has now decided ...
PharmiWeb17h
Renovos Biologics strengthens its Board’s US expertise with appointment of Lisa Ferrara, Ph.D., as a Non-Executive Director
Lisa Ferrara, Ph.D., brings over 30 years of experience in orthopaedic medical device innovation and regulatory strategy in the USA·       Dr Ferrara will play a pivotal role in advancing Renovos’ ...
Daily6d
FDA Approves lebrikizumab for treatment of atopic dermatitis
The US food and Drug Administration has approved lebrikizumab for treatment of atopic dermatitis in adults and children ages ...
ABS-CBN News on MSN4d
DOH: No FDA-registered mpox vaccine yet in PH
The Department of Health (DOH) reiterated that the Food and Drug Administration (FDA) has not approved any mpox vaccine to ...
Pharmabiz3d
US FDA approves Roche’s Ocrevus Zunovo to treat relapsing multiple sclerosis and PPMS
US FDA approves Roche’s Ocrevus Zunovo to treat relapsing multiple sclerosis and PPMS: Basel Tuesday, September 17, 2024, 10:00 Hrs [IST] Roche announced that the United States ...
Roche's Antiviral Drug Reduces Transmission Of Influenza Viruses, Late-Stage Study Shows
Roche Holdings AG (OTC:RHHBY) released positive topline results of the phase 3 CENTERSTONE study of Xofluza (baloxavir ...